|
|
Fibrogen Inc (NASDAQ: FGEN) |
|
*Market share is calculated based on total revenue.
News about Fibrogen Inc Contracts |
May 23, 2024
FibroGen Showcases Clinical Breakthroughs in Cancer Therapy at ASCO 2024 and Upcoming KOL Investor Event SAN FRANCISCO, May 23, 2024 - FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company committed to pioneering therapeutic advancements for serious unmet medical needs, is celebrating a significant milestone with the announcement of positive interim data from the dose escalation portion of the Phase 1b/2 study of FG-3246 (FOR46). This study is conducted by the University of California San Francisco and is designed to evaluate the efficacy of FG-3246, a potential first-in-class anti-CD46 antibody drug conjugate (ADC) containing an MMAE payload, in combination with enzalutamide in patients suffe...
|
April 2, 2024
This article provides an overview of the topline results from the Phase 1 study conducted by FibroGen, Inc. and sponsored by Fortis Therapeutics. The study evaluated the potential of FG-3246, an anti-CD46 antibody drug conjugate (ADC) with an MMAE-containing payload, as a treatment option for patients with metastatic castration-resistant prostate cancer (mCRPC) who have previously progressed on androgen receptor-signaling inhibitors (ARSI).Study Details:The Phase 1 trial was designed as a dose-escalation and dose-expansion study, aiming to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of FG-3246 in mCRPC patients. The trial enrolled participants with progressive tumors despite ...
|
February 26, 2024
FibroGen, a leading biopharmaceutical company, has recently announced that it has regained all rights to its innovative therapeutic drug, Roxadustat, from AstraZeneca, with the exception of China and South Korea. The decision marks a significant development in the partnership between both companies. The FibroGen AstraZeneca China Agreement for Roxadustat will remain intact, underscoring the importance of this medication in the Chinese market. Roxadustat is a revolutionary drug designed to treat anemia caused by chronic kidney disease (CKD) in patients who are both on dialysis and not on dialysis. The medication has shown promising results in clinical trials, demonstrating its ability to raise hemoglobin leve...
|
February 5, 2024
FibroGen, Inc. (NASDAQ: FGEN) has recently announced its plans to host...
|
Publicly Traded Peers of Fibrogen Inc
Aravive Inc
Share Performance
-75.37%
This Quarter
|
Aravive Inc
Profile
Aravive Inc operates on a business model that focuses on developing and commercializing innovative therapies to treat life-threatening diseases by targeting key signaling pathways.
More about Aravive Inc 's Market Share
|
Atossa Therapeutics Inc
Share Performance
-28.35%
This Quarter
|
Atossa Therapeutics Inc
Profile
Atossa Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for breast conditions and oncology.
More about Atossa Therapeutics Inc 's Market Share
|
Akebia Therapeutics Inc
Share Performance
-21.25%
30 Days
|
Akebia Therapeutics Inc
Profile
Akebia Therapeutics Inc's business model revolves around the development and commercialization of innovative therapies for kidney disease.
More about Akebia Therapeutics Inc 's Market Share
|
Amgen Inc
Share Performance
-12.18%
30 Days
|
Amgen Inc
Profile
Amgen Inc.s business model focuses on leveraging advanced biotechnology to create therapeutic products for various diseases, particularly in the fields of oncology, inflammation, and cardiovascular health. The company invests heavily in research and development to drive innovation, while also utilizing strategic partnerships and acquisitions to enhance its product pipeline. Additionally, Amgen emphasizes a strong global commercial presence to maximize the accessibility and impact of its therapeutics in the healthcare market.
More about Amgen Inc 's Market Share
|
Gilead Sciences Inc
Share Performance
+13.83%
This Quarter
|
Gilead Sciences Inc
Profile
Gilead Sciences Incs business model centers on researching, developing, and marketing innovative medicines, primarily targeting antiviral therapies. They focus on addressing unmet medical needs to enhance patient health globally.
More about Gilead Sciences Inc 's Market Share
|
Regeneron Pharmaceuticals Inc
Share Performance
-3.26%
Over The Past 5 Days
|
Regeneron Pharmaceuticals Inc
Profile
Regeneron Pharmaceuticals Inc operates a business model centered on the discovery and commercialization of cutting-edge biopharmaceuticals, particularly in the fields of ophthalmology, oncology, immunology, and rare diseases. They leverage their strong research and development capabilities, including their proprietary technologies, to create innovative therapies that address unmet medical needs. Additionally, Regeneron forms strategic collaborations and partnerships to enhance their development pipeline and expand market access for their products.
More about Regeneron Pharmaceuticals Inc 's Market Share
|
Vertex Pharmaceuticals Inc
Share Performance
+18.56%
This Quarter
|
Vertex Pharmaceuticals Inc
Profile
Vertex Pharmaceuticals Incs business model centers on the research and development of innovative therapies, primarily targeting cystic fibrosis and other serious diseases. They emphasize collaboration with organizations, strategic partnerships, and robust investment in R&D to deliver transformative treatments to patients and enhance their quality of life.
More about Vertex Pharmaceuticals Inc's Market Share
|
Moderna Inc
Share Performance
-24.53%
This Quarter
|
Moderna Inc
Profile
Moderna Inc's business model revolves around the development and commercialization of mRNA-based therapeutics and vaccines. They focus on using messenger RNA (mRNA) technology to create drugs that can help prevent and treat various diseases.
More about Moderna Inc 's Market Share
|
Cryo cell International Inc
Share Performance
-25.26%
This Year
|
Cryo cell International Inc
Profile
Cryo Cell International Inc's business model revolves around providing innovative services in stem cell banking and preservation.
More about Cryo cell International Inc 's Market Share
|
Transcode Therapeutics Inc
Share Performance
+4.33%
Over The Past 5 Days
|
Transcode Therapeutics Inc
Profile
Transcode Therapeutics Inc's business model revolves around developing innovative RNA-based therapies to treat a wide range of diseases. By leveraging their expertise in mRNA biology and proprietary drug delivery technology, they aim to create transformative treatments with optimized safety and efficacy profiles.
More about Transcode Therapeutics Inc 's Market Share
|
Elicio Therapeutics Inc
Share Performance
-3.11%
This Year
|
Elicio Therapeutics Inc
Profile
Elicio Therapeutics Inc is a biotechnology company that focuses on developing novel immunotherapies for treating cancer and other diseases. Their business model involves leveraging proprietary technology platforms to design and manufacture therapeutic vaccines and immune modulators, aiming to provide targeted and personalized treatment options.
More about Elicio Therapeutics Inc 's Market Share
|
Abcellera Biologics Inc
Share Performance
-19.54%
This Year
|
Abcellera Biologics Inc
Profile
Abcellera Biologics Inc is a biotechnology company that specializes in discovering and developing therapeutic antibodies.
More about Abcellera Biologics Inc 's Market Share
|
Siga Technologies Inc
Share Performance
-29.73%
One Year
|
Siga Technologies Inc
Profile
Siga Technologies Inc is a biotechnology company that focuses on the development and commercialization of pharmaceutical products. Their business model revolves around conducting research and development to create innovative therapies for diseases with unmet medical needs. They aim to generate revenue through the sale of their products and securing partnerships and collaborations with other pharmaceutical companies.
More about Siga Technologies Inc's Market Share
|
Arcus Biosciences Inc
Share Performance
-44.19%
This Quarter
|
Arcus Biosciences Inc
Profile
Arcus Biosciences Inc is a biotechnology company that focuses on developing immuno-oncology therapies. Their business model revolves around discovering and developing novel small molecule and antibody therapeutics to target various cancer indications. They aim to combine their extensive understanding of the immune system with innovative technology platforms to create effective treatments for patients with cancer.
More about Arcus Biosciences Inc 's Market Share
|
Moonlake Immunotherapeutics
Share Performance
-31.36%
This Year
|
Moonlake Immunotherapeutics
Profile
Moonlake Immunotherapeutics's business model revolves around the development and commercialization of innovative immunotherapies for the treatment of diseases.
More about Moonlake Immunotherapeutics's Market Share
|
Pyxis Oncology Inc
Share Performance
-79.14%
One Year
|
Pyxis Oncology Inc
Profile
Pyxis Oncology Inc is a biotechnology company focused on developing innovative cancer therapies. Their business model revolves around leveraging novel insights into the immune system to develop a pipeline of potential immunotherapies for cancer treatment. Pyxis Oncology aims to collaborate with strategic partners to advance their therapies through preclinical and clinical development, ultimately aiming to improve patient outcomes in the field of oncology.
More about Pyxis Oncology Inc 's Market Share
|
Atreca inc
Share Performance
-57.55%
This Quarter
|
Atreca inc
Profile
Atreca Inc operates on a unique business model focused on developing novel therapeutics by leveraging its proprietary Immune Repertoire Capture (IRC) technology to analyze and identify antibodies present in patients with specific diseases, ultimately enabling the development of targeted therapies.
More about Atreca inc 's Market Share
|
Unity Biotechnology Inc
Share Performance
-33.74%
One Year
|
Unity Biotechnology Inc
Profile
Unity Biotechnology Inc. is a biotechnology company that focuses on developing therapies to treat age-related diseases. Their business model revolves around identifying and targeting specific senescent cells to address age-related conditions like osteoarthritis, kidney disease, and ophthalmic diseases. By leveraging their expertise in cellular senescence, Unity Biotechnology aims to develop innovative treatments that have the potential to extend healthy human lifespan.
More about Unity Biotechnology Inc 's Market Share
|
Globestar Therapeutics Corporation
Share Performance
-77.78%
One Year
|
Globestar Therapeutics Corporation
Profile
Globestar Therapeutics Corporation's business model is focused on providing therapeutic solutions through innovative products and services aimed at improving healthcare outcomes.
More about Globestar Therapeutics Corporation's Market Share
|
Dmk Pharmaceuticals Corporation
Share Performance
-65.61%
This Year
|
Dmk Pharmaceuticals Corporation
Profile
DMK Pharmaceuticals Corporation has a business model focused on the development, manufacturing, and distribution of pharmaceutical products.
More about Dmk Pharmaceuticals Corporation's Market Share
|
Alaunos Therapeutics Inc
Share Performance
-4.90%
Over The Past 5 Days
|
Alaunos Therapeutics Inc
Profile
Alaunos Therapeutics Inc is a biotechnology company that operates on a research and development business model. Their focus is on discovering and developing innovative therapies for various diseases and medical conditions. Through their scientific expertise and collaborations, they aim to bring novel treatments to market to improve patient outcomes.
More about Alaunos Therapeutics Inc 's Market Share
|
Vincerx Pharma Inc
Share Performance
+80.09%
This Quarter
|
Vincerx Pharma Inc
Profile
Vincerx Pharma Inc's business model is focused on developing and commercializing novel small molecule drugs for the treatment of cancer. They aim to leverage their scientific expertise and collaborations to identify and advance promising drug candidates, ultimately providing innovative therapies to patients in need.
More about Vincerx Pharma Inc 's Market Share
|
Renovorx Inc
Share Performance
-36.17%
This Quarter
|
Renovorx Inc
Profile
Renovorx Inc is a medical technology company specializing in the development of innovative treatments for cardiovascular diseases. Their business model focuses on creating and commercializing minimally invasive therapies for patients suffering from conditions like myocardial infarction and heart failure. By leveraging cutting-edge medical devices and procedures, Renovorx aims to provide effective and efficient treatments that can significantly improve patient outcomes and quality of life.
More about Renovorx Inc 's Market Share
|
Hcw Biologics Inc
Share Performance
-13.02%
Over The Past 5 Days
|
Hcw Biologics Inc
Profile
HCW Biologics Inc is a biotechnology company that operates on a business model focused on the research, development, and commercialization of biologic therapies. The company primarily focuses on developing and manufacturing novel biological products for various medical conditions. Their business model involves collaboration with industry partners, conducting clinical trials, and securing regulatory approvals for the commercialization of their biologic therapies.
More about Hcw Biologics Inc 's Market Share
|
Moleculin Biotech Inc
Share Performance
-80.16%
One Year
|
Moleculin Biotech Inc
Profile
Moleculin Biotech Inc is a biopharmaceutical company that develops innovative cancer therapies by targeting key enzymes and signaling pathways involved in the progression of tumors. Their business model revolves around conducting preclinical and clinical trials to advance their drug candidates, with a focus on maximizing therapeutic impact and commercial potential.
More about Moleculin Biotech Inc 's Market Share
|
Vbi Vaccines Inc
Share Performance
-91.96%
30 Days
|
Vbi Vaccines Inc
Profile
Vbi Vaccines Inc is a biopharmaceutical company that focuses on the development and commercialization of a new generation of vaccines and immunotherapies. Their business model revolves around leveraging their proprietary technologies to create innovative products that target a range of infectious diseases and immune-oncology indications. By conducting rigorous research and clinical trials, Vbi Vaccines aims to bring these novel therapies to market and address unmet medical needs.
More about Vbi Vaccines Inc's Market Share
|
Exicure Inc
Share Performance
+1,831.58%
One Year
|
Exicure Inc
Profile
Exicure Inc operates on a business model focused on developing and commercializing transformative gene therapy drugs utilizing its proprietary spherical nucleic acid (SNA) technology. The company aims to leverage its platform to create therapeutic solutions for various diseases by delivering genetic medicines directly to cells. By collaborating with partners or independently, Exicure Inc aims to advance its pipeline and ultimately bring innovative treatments to the market.
More about Exicure Inc 's Market Share
|
Applied Molecular Transport Inc
Share Performance
-4.19%
Over The Past 5 Days
|
Applied Molecular Transport Inc
Profile
Applied Molecular Transport Inc (AMT) is a biopharmaceutical company focused on developing and commercializing transformative oral biologic therapeutics. The company utilizes its proprietary drug delivery technology platform to transport biologic drugs across the gastrointestinal tract and deliver them to target tissues. AMT's business model involves partnering with pharmaceutical companies to license its technology and collaborate on the development, manufacturing, and commercialization of oral biologic therapeutics.
More about Applied Molecular Transport Inc 's Market Share
|
Integrated Biopharma Inc
Share Performance
-9.35%
This Year
|
Integrated Biopharma Inc
Profile
Integrated Biopharma Inc's business model can be described as a vertically integrated health and wellness company focused on producing and distributing nutritional and dietary supplements.
More about Integrated Biopharma Inc's Market Share
|
Oncorus Inc
Share Performance
+401.99%
This Quarter
|
Oncorus Inc
Profile
Oncorus Inc is a biotechnology company that specializes in developing next-generation viral immunotherapies to treat various types of cancers. Their business model revolves around leveraging the power of oncolytic viruses, which selectively target and destroy cancer cells while stimulating an immune response against the tumor. Oncorus focuses on rigorous research, clinical development, and potential partnerships to advance their innovative therapies towards commercialization and widespread patient access.
More about Oncorus Inc 's Market Share
|
Evelo Biosciences Inc
Share Performance
0.00%
This Quarter
|
Evelo Biosciences Inc
Profile
Evelo Biosciences Inc is a biotechnology company focused on developing therapies for the treatment of various diseases. Their business model revolves around harnessing the potential of the body's own immune system through the development of monoclonal microbials. These microbials are designed to interact with the gut to elicit specific therapeutic effects, offering a novel approach to addressing medical conditions.
More about Evelo Biosciences Inc 's Market Share
|
Actavia Life Sciences Inc
Share Performance
0.00%
One Year
|
Actavia Life Sciences Inc
Profile
Rasna Therapeutics Inc is a biotechnology company that focuses on developing innovative therapies for the treatment of cancer and other diseases. Their business model revolves around leveraging cutting-edge research and technology to discover and develop novel drug candidates. They aim to partner with pharmaceutical companies or license their intellectual property to bring their therapies to market and ultimately improve patient outcomes.
More about Actavia Life Sciences Inc 's Market Share
|
Arrowhead Pharmaceuticals Inc
Share Performance
-45.63%
One Year
|
Arrowhead Pharmaceuticals Inc
Profile
Arrowhead Pharmaceuticals Inc is a biopharmaceutical company that primarily focuses on developing RNA interference (RNAi) therapeutics to treat a wide range of diseases. Their business model revolves around discovering and optimizing RNAi-based drug candidates, conducting preclinical and clinical studies for regulatory approval, and ultimately licensing or partnering with larger pharmaceutical companies for commercialization. By leveraging RNAi technology, Arrowhead aims to address unmet medical needs and provide innovative treatments for patients.
More about Arrowhead Pharmaceuticals Inc 's Market Share
|
Imunon Inc
Share Performance
-1.33%
This Quarter
|
Imunon Inc
Profile
Imunon Inc's business model revolves around developing and commercializing innovative immunotherapy products.
More about Imunon Inc 's Market Share
|
Emergent Biosolutions Inc
Share Performance
-20.03%
30 Days
|
Emergent Biosolutions Inc
Profile
Emergent Biosolutions Inc's business model focuses on developing and manufacturing specialty products for the prevention and treatment of public health threats.
More about Emergent Biosolutions Inc 's Market Share
|
Alnylam Pharmaceuticals Inc
Share Performance
-5.07%
Over The Past 5 Days
|
Alnylam Pharmaceuticals Inc
Profile
Alnylam Pharmaceuticals Inc's business model focuses on developing and commercializing RNA interference (RNAi) therapeutics.
More about Alnylam Pharmaceuticals Inc 's Market Share
|
Opko Health Inc
Share Performance
+13.20%
One Year
|
Opko Health Inc
Profile
Opko Health Inc is a biotechnology and pharmaceutical company that operates through various business segments. The company primarily focuses on diagnostics, developing and commercializing novel diagnostic tests for various conditions. Additionally, Opko Health engages in the production and sale of pharmaceuticals and vaccines, as well as the research and development of new medical technologies.
More about Opko Health Inc 's Market Share
|
Sarepta Therapeutics Inc
Share Performance
-54.40%
This Quarter
|
Sarepta Therapeutics Inc
Profile
Sarepta Therapeutics Inc's business model centers around the research, development, and commercialization of innovative genetic medicines for rare diseases, with a particular focus on Duchenne muscular dystrophy (DMD).
More about Sarepta Therapeutics Inc 's Market Share
|
Ionis Pharmaceuticals Inc
Share Performance
-17.26%
30 Days
|
Ionis Pharmaceuticals Inc
Profile
Ionis Pharmaceuticals Inc is a biopharmaceutical company that operates on a two-fold business model. Firstly, the company focuses on discovering and developing antisense drugs, utilizing a unique RNA-targeted technology. Secondly, Ionis collaborates with established pharmaceutical partners to license and commercialize their drugs, allowing for maximum reach and potential commercial success.
More about Ionis Pharmaceuticals Inc's Market Share
|
Dynavax Technologies Corp
Share Performance
-11.55%
This Year
|
Dynavax Technologies Corp
Profile
Dynavax Technologies Corp operates through a business model focused on the development and commercialization of innovative vaccines. The company aims to leverage its expertise in immunology to create novel products that address unmet medical needs. Dynavax utilizes strategic collaborations and partnerships to advance its vaccine candidates and bring them to market efficiently.
More about Dynavax Technologies Corp's Market Share
|
Wave Life Sciences Ltd
Share Performance
-56.76%
This Year
|
Wave Life Sciences Ltd
Profile
Wave Life Sciences Ltd is a biotechnology company focused on developing and commercializing nucleic acid therapies for rare genetic diseases. Their business model revolves around utilizing their proprietary chemistry platform to design and create custom-built, targeted medicines that can potentially address a wide range of genetic disorders. They aim to bring these therapies through preclinical and clinical development stages and ultimately deliver innovative treatments to patients in need.
More about Wave Life Sciences Ltd 's Market Share
|
Eterna Therapeutics Inc
Share Performance
-90.73%
One Year
|
Eterna Therapeutics Inc
Profile
Eterna Therapeutics Inc is a biotechnology company that operates in the field of RNA therapeutics. Their business model focuses on developing innovative RNA-based therapies for various diseases by leveraging their proprietary platform technology. They aim to utilize their scientific expertise and strategic collaborations to advance the discovery, development, and commercialization of RNA therapeutics to improve patient outcomes.
More about Eterna Therapeutics Inc 's Market Share
|
Capricor Therapeutics inc
Share Performance
+4.47%
Over The Past 5 Days
|
Capricor Therapeutics inc
Profile
Capricor Therapeutics Inc's business model revolves around developing innovative regenerative medicine therapies for the treatment of diseases that have unmet medical needs.
More about Capricor Therapeutics inc 's Market Share
|
Centessa Pharmaceuticals Plc
Share Performance
-22.47%
This Quarter
|
Centessa Pharmaceuticals Plc
Profile
Centessa Pharmaceuticals Plc operates as a biopharmaceutical company that focuses on the discovery and development of innovative medicines. Their business model centers around leveraging a decentralized approach, with multiple subsidiary companies working autonomously to accelerate the research and development of potential therapeutics across various disease areas. By bringing together diverse expertise and resources, Centessa aims to efficiently advance breakthrough therapies and deliver impactful solutions to patients in need.
More about Centessa Pharmaceuticals Plc's Market Share
|
Nuvation Bio Inc
Share Performance
-22.31%
This Quarter
|
Nuvation Bio Inc
Profile
Nuvation Bio Inc's business model is centered around the development of novel therapies for the treatment of cancer and other diseases.
More about Nuvation Bio Inc 's Market Share
|
Contrafect Corporation
Share Performance
-64.34%
One Year
|
Contrafect Corporation
Profile
ContraFect Corporation is a biotechnology company that focuses on the development of protein and antibody-based therapies to treat drug-resistant infectious diseases.
More about Contrafect Corporation's Market Share
|
Altimmune Inc
Share Performance
-24.12%
30 Days
|
Altimmune Inc
Profile
Altimmune Inc's business model is focused on developing and commercializing innovative immunotherapies for treating infectious diseases and improving immune responses.
More about Altimmune Inc 's Market Share
|
Ibio inc
Share Performance
-54.55%
This Year
|
Ibio inc
Profile
Ibio Inc is a plant-based biologics company that focuses on the development and manufacturing of therapeutic proteins. They utilize their proprietary plant-based expression system to produce biotherapeutics quickly and cost-effectively. By leveraging their platform, Ibio aims to address unmet medical needs and provide affordable and accessible treatments to patients worldwide.
More about Ibio inc 's Market Share
|
Alpine Immune Sciences Inc
Share Performance
+241.95%
This Year
|
Alpine Immune Sciences Inc
Profile
Alpine Immune Sciences Inc is a biotechnology company focused on developing immunotherapies to treat cancer and autoimmune diseases. Their business model involves identifying unique protein targets and using their proprietary technology platform to engineer and develop novel therapeutic antibodies that modulate the immune system. They aim to partner with pharmaceutical companies for the clinical development and commercialization of their product candidates.
More about Alpine Immune Sciences Inc 's Market Share
|
Arcturus Therapeutics Holdings Inc
Share Performance
-64.92%
One Year
|
Arcturus Therapeutics Holdings Inc
Profile
Arcturus Therapeutics Holdings Inc is a biopharmaceutical company that focuses on the development of RNA medicines. Their business model involves leveraging their proprietary LUNAR lipid-mediated delivery platform to create and commercialize mRNA-based therapeutics for treating various diseases. By utilizing this platform, they aim to partner with pharmaceutical companies to bring their innovative therapies to patients globally.
More about Arcturus Therapeutics Holdings Inc 's Market Share
|
Pfizer Inc
Share Performance
-12.78%
One Year
|
Pfizer Inc
Profile
Pfizer Inc operates as a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing innovative medicines. Its business model emphasizes significant investment in research and development to build a diverse portfolio of therapies across various therapeutic areas, while leveraging strategic alliances and collaborations to enhance commercialization and drive growth.
More about Pfizer Inc's Market Share
|
Johnson and Johnson
Share Performance
+3.78%
Over The Past 5 Days
|
Johnson and Johnson
Profile
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
More about Johnson and Johnson's Market Share
|
Sanofi
Share Performance
+5.00%
This Year
|
Sanofi
Profile
Sanofi's business model revolves around the development, production, and distribution of pharmaceutical products. They aim to innovate and provide healthcare solutions across various therapeutic areas to improve patients' lives worldwide. Sanofi collaborates with partners and healthcare professionals to ensure effective delivery of their products and to address evolving patient needs.
More about Sanofi's Market Share
|
Astrazeneca Plc
Share Performance
-12.28%
30 Days
|
Astrazeneca Plc
Profile
AstraZeneca Plc is a global biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. Their business model involves investing extensively in research and development to discover novel treatments for a wide range of diseases. AstraZeneca then markets and sells these medicines globally, collaborating with healthcare providers and leveraging their strong sales and distribution networks.
More about Astrazeneca Plc's Market Share
|
Xencor Inc
Share Performance
+10.42%
Over The Past 5 Days
|
Xencor Inc
Profile
Xencor Inc is a biotechnology company that primarily focuses on the development of therapeutic antibodies. Their business model revolves around utilizing their proprietary XmAb? technology to engineer antibodies with enhanced properties for the treatment of various diseases. They collaborate with pharmaceutical companies to develop and commercialize these antibody therapeutics, generating revenue through upfront payments, milestone payments, and royalties.
More about Xencor Inc's Market Share
|
Cohbar Inc
Share Performance
-6.82%
30 Days
|
Cohbar Inc
Profile
Cohbar Inc is a biotechnology company that focuses on the discovery and development of peptide-based therapeutics for the treatment of age-related diseases. Their business model revolves around leveraging their proprietary peptide technology platform and partnerships with pharmaceutical companies to advance and commercialize their drug candidates.
More about Cohbar Inc 's Market Share
|
Precigen Inc
Share Performance
+28.70%
This Year
|
Precigen Inc
Profile
Precigen Inc is a biotechnology company that focuses on the development and commercialization of innovative genetic therapies. Their business model revolves around leveraging their proprietary technologies and expertise in gene editing and synthetic biology to create transformative medical solutions. With a strong emphasis on research and development, Precigen aims to bring cutting-edge genetic therapies to market and address critical unmet medical needs.
More about Precigen Inc 's Market Share
|
Vaxxinity Inc
Share Performance
-75.00%
Over The Past 5 Days
|
Vaxxinity Inc
Profile
Vaxxinity Inc is a company that operates on a business model that focuses on the development and distribution of vaccines.
More about Vaxxinity Inc 's Market Share
|
Nanoviricides inc
Share Performance
+12.71%
One Year
|
Nanoviricides inc
Profile
Nanoviricides Inc. is a pharmaceutical company that operates on a business model based on the development and commercialization of nanomedicines.
More about Nanoviricides inc 's Market Share
|
Geovax Labs Inc
Share Performance
-62.22%
This Quarter
|
Geovax Labs Inc
Profile
Geovax Labs Inc's business model primarily focuses on the development and commercialization of innovative vaccines to prevent and treat diseases, with a particular emphasis on HIV/AIDS. They aim to bridge the gap in preventing and managing these diseases through their vaccine candidates and strategic partnerships.
More about Geovax Labs Inc 's Market Share
|
Cocrystal Pharma Inc
Share Performance
-42.24%
This Year
|
Cocrystal Pharma Inc
Profile
Cocrystal Pharma Inc.'s business model focuses on the development of antiviral therapeutics to address unmet medical needs.
More about Cocrystal Pharma Inc 's Market Share
|
Lianbio
Share Performance
-81.01%
One Year
|
Lianbio
Profile
LianBio is a biopharmaceutical company that focuses on accelerating the development and commercialization of innovative medicines in the Chinese market. They collaborate with global partners to identify and acquire promising drug candidates, providing them with regulatory expertise and commercialization capabilities. By leveraging their deep understanding of the Chinese healthcare landscape, LianBio aims to bridge the gap between global innovation and Chinese patient needs.
More about Lianbio's Market Share
|
Indaptus Therapeutics Inc
Share Performance
-81.92%
One Year
|
Indaptus Therapeutics Inc
Profile
Indaptus Therapeutics Inc's business model focuses on developing and commercializing innovative therapies in the healthcare industry.
More about Indaptus Therapeutics Inc 's Market Share
|
Pardes Biosciences Inc
Share Performance
-38.46%
One Year
|
Pardes Biosciences Inc
Profile
Pardes Biosciences Inc operates on a subscription-based model, offering comprehensive biotechnology research and analysis services to its clients. The company provides customized solutions and expertise in areas such as drug discovery, genomics, and molecular biology, catering to the specific needs of pharmaceutical companies, research institutions, and medical professionals. By leveraging cutting-edge technology and a team of experienced scientists, Pardes Biosciences aims to accelerate scientific breakthroughs and contribute to advancements in the field of life sciences.
More about Pardes Biosciences Inc 's Market Share
|
Altamira Therapeutics Ltd
Share Performance
-30.88%
Over The Past 5 Days
|
Altamira Therapeutics Ltd
Profile
Altamira Therapeutics Ltd's business model revolves around developing and commercializing innovative therapeutics.
More about Altamira Therapeutics Ltd 's Market Share
|
Benitec Biopharma Inc
Share Performance
+13.25%
This Year
|
Benitec Biopharma Inc
Profile
Benitec Biopharma Inc is a biotechnology company that focuses on developing and commercializing gene therapy products. They utilize their proprietary RNA interference technology to target and silence disease-causing genes, ultimately aiming to provide effective treatment options for various genetic diseases.
More about Benitec Biopharma Inc 's Market Share
|
Xenetic Biosciences Inc
Share Performance
-40.58%
One Year
|
Xenetic Biosciences Inc
Profile
Xenetic Biosciences Inc is a biopharmaceutical company that focuses on developing personalized therapeutics with the potential to improve patient outcomes. The company employs a business model centered around leveraging its proprietary drug development platform to partner with pharmaceutical companies and advance novel drug candidates through preclinical and clinical stages.
More about Xenetic Biosciences Inc 's Market Share
|
Synlogic Inc
Share Performance
-23.40%
This Year
|
Synlogic Inc
Profile
Synlogic Inc's business model revolves around utilizing synthetic biology to develop innovative microbial engineering solutions. They focus on developing Synthetic Biotic medicines, which are living medicines designed to treat diseases by targeting specific metabolic or immuno-inflammatory pathways in the body.
More about Synlogic Inc 's Market Share
|
Curevac N v
Share Performance
-6.38%
This Year
|
Curevac N v
Profile
CureVac N.V. is a biopharmaceutical company focused on developing and manufacturing innovative mRNA-based therapeutics and vaccines. Their business model involves leveraging their proprietary technology platform to develop a diverse pipeline of potential mRNA-based products, from early-stage research to clinical trials. CureVac N.V. collaborates with partners and organizations to advance their product candidates, aiming to address unmet medical needs and improve patient outcomes.
More about Curevac N v 's Market Share
|
Xbiotech Inc
Share Performance
-20.42%
This Quarter
|
Xbiotech Inc
Profile
Xbiotech Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic antibodies. They seek to address unmet medical needs by leveraging their proprietary True Human antibody technology.
More about Xbiotech Inc 's Market Share
|
Briacell Therapeutics Corp
Share Performance
-7.86%
30 Days
|
Briacell Therapeutics Corp
Profile
Briacell Therapeutics Corp's business model is centered around the development and commercialization of personalized immunotherapies for the treatment of cancer.
More about Briacell Therapeutics Corp 's Market Share
|
Fulcrum Therapeutics Inc
Share Performance
-37.19%
This Year
|
Fulcrum Therapeutics Inc
Profile
Fulcrum Therapeutics Inc operates as a biopharmaceutical company that focuses on developing personalized therapies for genetically defined diseases. Their business model involves leveraging their proprietary product engine to identify and target specific gene regulatory networks to address the root causes of diseases.
More about Fulcrum Therapeutics Inc 's Market Share
|
Tango Therapeutics Inc
Share Performance
-58.63%
This Year
|
Tango Therapeutics Inc
Profile
Tango Therapeutics Inc is a biotechnology company that focuses on developing cancer therapies using DNA sequencing and computational biology. Their business model revolves around discovering and developing precision medicines by leveraging their expertise in genomics and biology to target specific cancer vulnerabilities.
More about Tango Therapeutics Inc 's Market Share
|
Theravance Biopharma inc
Share Performance
-7.38%
30 Days
|
Theravance Biopharma inc
Profile
Theravance Biopharma Inc's business model focuses on developing and commercializing innovative therapeutics to address unmet medical needs in various therapeutic areas.
More about Theravance Biopharma inc 's Market Share
|
Third Harmonic Bio Inc
Share Performance
-9.86%
This Quarter
|
Third Harmonic Bio Inc
Profile
Third Harmonic Bio Inc's business model centers around developing and commercializing innovative therapeutic solutions through the utilization of bioinformatics and genomics.
More about Third Harmonic Bio Inc 's Market Share
|
Roivant Sciences Ltd
Share Performance
+1.72%
Over The Past 5 Days
|
Roivant Sciences Ltd
Profile
Roivant Sciences Ltd operates as a biopharmaceutical company that focuses on acquiring and developing therapeutics in various therapeutic areas.
More about Roivant Sciences Ltd 's Market Share
|
Avidity Biosciences Inc
Share Performance
+11.59%
One Year
|
Avidity Biosciences Inc
Profile
Avidity Biosciences Inc's business model revolves around developing and commercializing potential therapeutics using its proprietary AOC platform, which enables the targeted delivery of drugs to specific cells in the body.
More about Avidity Biosciences Inc 's Market Share
|
Immunome Inc
Share Performance
-18.14%
30 Days
|
Immunome Inc
Profile
Immunome Inc is a biotechnology company that focuses on developing novel immunotherapies. Their business model revolves around leveraging their proprietary discovery engine to identify therapeutic antibodies for infectious diseases and cancer. By collaborating with partners and through their own clinical development efforts, they aim to bring these promising treatments to the market.
More about Immunome Inc's Market Share
|
Silence Therapeutics Plc
Share Performance
-86.82%
One Year
|
Silence Therapeutics Plc
Profile
Silence Therapeutics Plc is a biomedical company that specializes in the discovery, development, and commercialization of innovative RNA-based therapeutics. They employ a business model focused on leveraging their proprietary technology to develop a pipeline of therapeutics targeting various diseases with high unmet medical needs. Through strategic partnerships and licensing agreements, they aim to deliver transformative RNA-based treatments to patients globally.
More about Silence Therapeutics Plc's Market Share
|
Xoma Royalty Corporation
Share Performance
+3.08%
Over The Past 5 Days
|
Xoma Royalty Corporation
Profile
Xoma Corporation operates under a business model focused on the development and commercialization of novel therapeutics. The company primarily concentrates on creating antibody-based therapies to address unmet medical needs. Xoma also engages in collaborations and partnerships with other pharmaceutical companies to advance their product pipeline and expand their reach in the market.
More about Xoma Royalty Corporation's Market Share
|
An2 Therapeutics Inc
Share Performance
-48.99%
One Year
|
An2 Therapeutics Inc
Profile
An2 Therapeutics Inc is a biotechnology company that develops therapeutics for the treatment of rare diseases. Their business model focuses on research and development of innovative drugs that target specific genetic mutations responsible for these rare conditions, aiming to provide effective and personalized treatments. By collaborating with pharmaceutical partners and leveraging their expertise in drug discovery, An2 Therapeutics Inc aims to bring their therapies to market and improve the lives of patients with rare diseases.
More about An2 Therapeutics Inc 's Market Share
|
Anaptysbio Inc
Share Performance
+35.48%
This Year
|
Anaptysbio Inc
Profile
AnaptysBio is a biotechnology company that operates on a partnership-driven business model. They collaborate with pharmaceutical companies to develop and commercialize novel antibody therapeutics using their proprietary antibody discovery technology. By leveraging their expertise in antibody engineering and discovery, AnaptysBio aims to create innovative treatments for a wide range of diseases, including inflammation, immuno-oncology, and rare diseases.
More about Anaptysbio Inc 's Market Share
|
Agios Pharmaceuticals Inc
Share Performance
-12.63%
This Year
|
Agios Pharmaceuticals Inc
Profile
Agios Pharmaceuticals Inc is a biopharmaceutical company that focuses on researching and developing innovative therapies for treating genetic diseases and cancer.
More about Agios Pharmaceuticals Inc 's Market Share
|
Bridgebio Pharma Inc
Share Performance
+3.73%
30 Days
|
Bridgebio Pharma Inc
Profile
BridgeBio Pharma Inc is a biopharmaceutical company that focuses on developing and commercializing precision medicines for genetic diseases and cancers. Their business model involves identifying and acquiring early-stage drug candidates, conducting clinical trials, and partnering with other companies for commercialization.
More about Bridgebio Pharma Inc 's Market Share
|
Structure Therapeutics Inc
Share Performance
+23.77%
Over The Past 5 Days
|
Structure Therapeutics Inc
Profile
Structure Therapeutics Inc is a biotechnology company that utilizes a structure-based approach to develop innovative therapeutics. They focus on identifying and targeting unique protein structures to create novel drugs for various diseases.
More about Structure Therapeutics Inc 's Market Share
|
Prometheus Biosciences Inc
Share Performance
+87.54%
This Year
|
Prometheus Biosciences Inc
Profile
Prometheus Biosciences Inc is a biotechnology company that operates on a subscription-based business model. Their platform offers personalized diagnostic tools and services to healthcare providers, enabling them to deliver targeted treatments for patients with gastrointestinal diseases. By providing ongoing support and monitoring, Prometheus aims to improve patient outcomes and revolutionize the management of chronic conditions in the field of gastroenterology.
More about Prometheus Biosciences Inc 's Market Share
|
Nektar Therapeutics
Share Performance
-33.57%
This Year
|
Nektar Therapeutics
Profile
Nektar Therapeutics operates under a business model focused on developing and commercializing innovative medicines. The company's approach involves utilizing its proprietary technology platforms to create novel therapeutic candidates and establish partnerships with pharmaceutical and biotechnology firms for clinical development and commercialization. Nektar Therapeutics aims to bring transformative therapies to market that address significant unmet medical needs.
More about Nektar Therapeutics's Market Share
|
Mannkind Corporation
Share Performance
-29.70%
This Year
|
Mannkind Corporation
Profile
MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of inhaled therapeutic solutions for patients with diseases such as diabetes and pulmonary arterial hypertension. The company's business model revolves around conducting research and development to create innovative inhalation therapies and gaining regulatory approvals for these treatments. They then market and distribute their products, either directly or through partnerships, to healthcare providers and patients worldwide.
More about Mannkind Corporation's Market Share
|
Arvinas Inc
Share Performance
-77.33%
One Year
|
Arvinas Inc
Profile
Arvinas Inc's business model revolves around developing novel therapies based on protein degradation technology to address unmet medical needs.
More about Arvinas Inc 's Market Share
|
Morphosys Ag
Share Performance
+4.18%
30 Days
|
Morphosys Ag
Profile
Morphosys Ag's business model revolves around the development and commercialization of therapeutic antibodies.
More about Morphosys Ag's Market Share
|
Puma Biotechnology Inc
Share Performance
-14.07%
30 Days
|
Puma Biotechnology Inc
Profile
Puma Biotechnology Inc operates as a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. Their business model revolves around identifying promising preclinical and clinical drug candidates, conducting rigorous research and development, and seeking regulatory approval for their products. Puma Biotechnology Inc strives to effectively market and distribute their approved therapeutics to provide patients with potentially life-saving treatment options.
More about Puma Biotechnology Inc 's Market Share
|
Innoviva Inc
Share Performance
+4.56%
Over The Past 5 Days
|
Innoviva Inc
Profile
Innoviva Inc's business model revolves around the development and commercialization of pharmaceutical products. The company primarily focuses on creating strategic collaborations and partnerships with biopharmaceutical companies to advance innovative therapies. Innoviva generates revenue through royalty payments received based on the sales of its partnered products.
More about Innoviva Inc 's Market Share
|
Atea Pharmaceuticals Inc
Share Performance
-15.06%
This Quarter
|
Atea Pharmaceuticals Inc
Profile
Atea Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing antiviral therapeutics to combat infectious diseases. Their business model revolves around identifying and advancing novel drug candidates that target specific viral mechanisms and inhibit their replication. This includes conducting preclinical and clinical trials, engaging in strategic partnerships, and ultimately bringing effective antiviral treatments to market.
More about Atea Pharmaceuticals Inc 's Market Share
|
Myovant Sciences Ltd
Share Performance
+0.37%
30 Days
|
Myovant Sciences Ltd
Profile
Myovant Sciences Ltd operates under a biopharmaceutical business model primarily focused on the development and commercialization of therapies for women's health and prostate cancer. The company aims to leverage its expertise in clinical research, regulatory affairs, and manufacturing to bring innovative treatments to market and improve patients' lives. Myovant Sciences employs a combination of in-house research and development along with collaboration with strategic partners to advance its pipeline of product candidates.
More about Myovant Sciences Ltd 's Market Share
|
Medicinova Inc
Share Performance
-7.89%
One Year
|
Medicinova Inc
Profile
Medicinova Inc operates under a biopharmaceutical business model, primarily focused on the development and commercialization of innovative therapeutics. They strive to identify promising drug candidates with the potential to address unmet medical needs and advance them through clinical trials. By leveraging their research capabilities, strategic partnerships, and licensing opportunities, Medicinova Inc aims to bring these novel treatments to market and improve patient outcomes.
More about Medicinova Inc 's Market Share
|
Alx Oncology Holdings Inc
Share Performance
-66.55%
This Quarter
|
Alx Oncology Holdings Inc
Profile
Alx Oncology Holdings Inc's business model is centered around the development and commercialization of innovative cancer therapeutics.
More about Alx Oncology Holdings Inc's Market Share
|
Biovie Inc
Share Performance
-25.35%
30 Days
|
Biovie Inc
Profile
Biovie Inc is a biotechnology company that aims to develop advanced therapeutic solutions for various diseases. They have a unique business model that focuses on research and development of innovative drugs, strategic partnerships and collaborations with other organizations, along with potential commercialization of their products to generate revenue. Their goal is to create groundbreaking medical treatments that improve the quality of life for patients.
More about Biovie Inc 's Market Share
|
Vera Therapeutics Inc
Share Performance
-2.64%
Over The Past 5 Days
|
Vera Therapeutics Inc
Profile
Vera Therapeutics Inc is a pharmaceutical company that specializes in developing and commercializing innovative therapies for patients with rare and serious diseases. Their business model focuses on researching and developing novel drug candidates, conducting clinical trials, and obtaining regulatory approvals to bring their products to market. By targeting niche patient populations with unmet medical needs, they aim to provide effective treatment options and improve patient outcomes.
More about Vera Therapeutics Inc 's Market Share
|
Astria Therapeutics inc
Share Performance
-54.29%
This Year
|
Astria Therapeutics inc
Profile
Astria Therapeutics Inc's business model centers around developing and commercializing innovative therapeutics for various diseases and medical conditions.
More about Astria Therapeutics inc 's Market Share
|
Xilio Therapeutics Inc
Share Performance
+3.68%
Over The Past 5 Days
|
Xilio Therapeutics Inc
Profile
Xilio Therapeutics Inc is a biotechnology company focused on developing and commercializing novel immunotherapies to treat cancer.
More about Xilio Therapeutics Inc 's Market Share
|
Prelude Therapeutics Inc
Share Performance
+16.92%
Over The Past 5 Days
|
Prelude Therapeutics Inc
Profile
Prelude Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative small molecule therapeutic products for cancer treatment. Their business model revolves around conducting extensive research and employing a target discovery engine to identify and validate potential drug targets. By using a combination of proprietary technologies and collaborations with academic institutions, Prelude Therapeutics aims to develop and commercialize novel oncology therapies to address unmet medical needs.
More about Prelude Therapeutics Inc's Market Share
|
Eqrx Inc
Share Performance
-6.02%
This Year
|
Eqrx Inc
Profile
Eqrx Inc is a pharmaceutical company that focuses on creating affordable and accessible medication. They employ an innovative business model that combines research and development with scientific expertise to develop generic alternatives to the high-priced drugs in the market. By bypassing the traditional pharmaceutical pricing system, Eqrx aims to make essential medications more affordable for patients and healthcare providers.
More about Eqrx Inc 's Market Share
|
Inflarx N v
Share Performance
-56.35%
This Quarter
|
Inflarx N v
Profile
Inflarx N is a company that operates on a B2B (business-to-business) model. They offer a range of services and products such as software solutions, data analytics, and consulting to businesses in the technology sector. Their revenue primarily comes from subscription fees, licensing, and consulting fees.
More about Inflarx N v 's Market Share
|
Therapeuticsmd Inc
Share Performance
-35.67%
This Year
|
Therapeuticsmd Inc
Profile
TherapeuticsMD Inc is a pharmaceutical company that focuses on developing and commercializing innovative hormone therapy products for women. Their business model revolves around research, development, and marketing of prescription and over-the-counter products catering to women's health needs. By leveraging strategic partnerships and collaborations, they aim to bring their products to market, ultimately improving the quality of life for women.
More about Therapeuticsmd Inc's Market Share
|
Legend Biotech Corporation
Share Performance
+5.17%
Over The Past 5 Days
|
Legend Biotech Corporation
Profile
Legend Biotech Corporation is a biotech company focused on developing innovative cell therapies and gene therapies to address unmet medical needs in various diseases.
More about Legend Biotech Corporation's Market Share
|
Beigene Ltd
Share Performance
+3.85%
One Year
|
Beigene Ltd
Profile
BeiGene Ltd is a biotechnology company that focuses on discovering, developing, and commercializing innovative medicines to meet the needs of cancer patients in China and worldwide. They follow a vertically integrated business model, with expertise in research and development, manufacturing, and commercialization, allowing them to have control over the entire drug development process. By leveraging strategic partnerships and collaborations, BeiGene aims to bring forth cutting-edge therapies and improve treatment options for cancer patients.
More about Beigene Ltd 's Market Share
|
Organon and Co
Share Performance
-0.54%
Over The Past 5 Days
|
Organon and Co
Profile
Organon and Co's business model revolves around developing and manufacturing pharmaceutical products.
More about Organon and Co 's Market Share
|
Teva Pharmaceutical Industries Limited
Share Performance
+0.99%
One Year
|
Teva Pharmaceutical Industries Limited
Profile
Teva Pharmaceutical Industries Limited is a multinational pharmaceutical company that focuses on the development, production, and marketing of generic and specialty medicines. They aim to provide affordable and accessible healthcare solutions to patients worldwide.
More about Teva Pharmaceutical Industries Limited's Market Share
|
Viatris Inc
Share Performance
-39.41%
This Year
|
Viatris Inc
Profile
Viatris Inc operates as a global pharmaceutical company, specializing in the development, manufacturing, and distribution of a wide range of generic and branded medicines, as well as biosimilars.
More about Viatris Inc 's Market Share
|
Novartis Ag
Share Performance
+17.95%
One Year
|
Novartis Ag
Profile
Novartis AG's business model is centered around the development, manufacturing, and marketing of innovative pharmaceutical products.
More about Novartis Ag's Market Share
|
Medicure Inc
Share Performance
0.00%
This Quarter
|
Medicure Inc
Profile
Medicure Inc operates as a pharmaceutical company with a business model that focuses on the research, development, and commercialization of innovative cardiovascular and other specialty pharmaceuticals. They aim to address unmet medical needs, improve patient outcomes, and deliver value to healthcare providers and consumers.
More about Medicure Inc 's Market Share
|
Allarity Therapeutics Inc
Share Performance
-98.33%
One Year
|
Allarity Therapeutics Inc
Profile
Allarity Therapeutics Inc is a biotechnology company that leverages its unique drug response profiling platform to develop personalized cancer treatments. They use AI algorithms to match patients with the most effective therapies by analyzing their individual molecular profiles.
More about Allarity Therapeutics Inc 's Market Share
|
Viracta Therapeutics Inc
Share Performance
-98.26%
One Year
|
Viracta Therapeutics Inc
Profile
Viracta Therapeutics Inc is a biopharmaceutical company focused on developing targeted therapies for viral-associated cancers. The company aims to advance research, develop innovative treatments, and commercialize products to improve the lives of patients suffering from these types of cancers.
More about Viracta Therapeutics Inc 's Market Share
|
Biophytis Sa
Share Performance
-63.73%
This Year
|
Biophytis Sa
Profile
Biophytis SA is a biotechnology company that focuses on developing innovative therapeutics for age-related diseases, with a specific emphasis on degenerative eye diseases and muscle wasting conditions. They leverage their expertise in biology and clinical development to discover and advance targeted drug candidates, aiming to address the unmet medical needs of patients in these areas.
More about Biophytis Sa's Market Share
|
Immuron Limited
Share Performance
-27.92%
One Year
|
Immuron Limited
Profile
Immuron Limited's business model involves the development and commercialization of oral immunotherapeutics that target and treat various diseases.
More about Immuron Limited's Market Share
|
Iterum Therapeutics Plc
Share Performance
0.00%
Over The Past 5 Days
|
Iterum Therapeutics Plc
Profile
Iterum Therapeutics Plc is a pharmaceutical company that focuses on the research, development, and commercialization of innovative anti-infectives for the treatment of serious and life-threatening infections. They aim to address unmet medical needs in this space by advancing their product candidates through clinical trials and ultimately bringing them to market.
More about Iterum Therapeutics Plc's Market Share
|
Esperion Therapeutics inc
Share Performance
-54.74%
This Year
|
Esperion Therapeutics inc
Profile
Esperion Therapeutics Inc's business model focuses on the development and commercialization of innovative therapies for addressing cardiovascular diseases.
More about Esperion Therapeutics inc 's Market Share
|
Cellectar Biosciences inc
Share Performance
-8.25%
This Year
|
Cellectar Biosciences inc
Profile
Cellectar Biosciences Inc is a biopharmaceutical company that focuses on the development of targeted cancer therapies. They utilize their proprietary drug conjugation platform to create targeted small molecules that can selectively bind and deliver radioactive isotopes directly to cancer cells. Their business model revolves around developing and commercializing these innovative therapies for the treatment of various types of cancer, aiming to improve patient outcomes and potentially revolutionize cancer treatment.
More about Cellectar Biosciences inc 's Market Share
|
Journey Medical Corp
Share Performance
+54.50%
This Year
|
Journey Medical Corp
Profile
Journey Medical Corporation is a pharmaceutical and medical device company that specializes in developing and commercializing innovative products for dermatology and aesthetics. Their business model revolves around conducting research and development to create new products, acquiring the necessary regulatory approvals, and partnering with healthcare professionals to effectively distribute and market these products. By focusing on dermatology and aesthetics, Journey Medical Corporation aims to address unmet medical needs and provide cutting-edge solutions to improve patient outcomes in these fields.
More about Journey Medical Corp's Market Share
|
Casi Pharmaceuticals inc
Share Performance
-5.69%
Over The Past 5 Days
|
Casi Pharmaceuticals inc
Profile
Casi Pharmaceuticals Inc. operates under a business model that focuses on the development and commercialization of innovative pharmaceutical products. They likely employ a combination of in-house research and development, partnerships, and licensing agreements to bring their products to market. The company may also engage in strategic marketing and distribution partnerships to ensure the successful commercialization of their therapeutics.
More about Casi Pharmaceuticals inc 's Market Share
|
Mineralys Therapeutics Inc
Share Performance
+13.31%
This Year
|
Mineralys Therapeutics Inc
Profile
Mineralys Therapeutics Inc is a biotechnology company that follows the business model of developing and commercializing novel therapeutics for various diseases. They focus on discovering and advancing small molecule drugs based on innovative research approaches. Their business model is centered around conducting preclinical and clinical trials, obtaining regulatory approvals, and ultimately bringing their therapeutic products to market for improved patient outcomes.
More about Mineralys Therapeutics Inc 's Market Share
|
Takeda Pharmaceutical Company Limited
Share Performance
+10.72%
This Year
|
Takeda Pharmaceutical Company Limited
Profile
Takeda Pharmaceutical Company Limited operates under a business model that primarily focuses on research, development, and commercialization of innovative pharmaceutical products. They collaborate with various stakeholders across the healthcare industry, including academia, biotechnology companies, and patient advocacy groups, to drive scientific advancements and understand patient needs. By leveraging their expertise, global presence, and strategic partnerships, Takeda aims to make a positive impact on patients' lives while ensuring long-term growth and sustainability.
More about Takeda Pharmaceutical Company Limited's Market Share
|
Bicycle Therapeutics Plc
Share Performance
-45.75%
This Year
|
Bicycle Therapeutics Plc
Profile
Bicycle Therapeutics Plc's business model is centered around the development and commercialization of novel therapeutics using its proprietary bicyclic peptide platform.
More about Bicycle Therapeutics Plc's Market Share
|
Chinook Therapeutics Inc
Share Performance
+3.27%
30 Days
|
Chinook Therapeutics Inc
Profile
Chinook Therapeutics is a biotechnology company focused on the development of precision medicines for kidney diseases and other rare disorders. Their business model revolves around identifying and targeting specific pathways involved in the progression of kidney diseases, leveraging innovative technologies and partnerships to develop novel therapies that can improve patient outcomes. By prioritizing the unmet needs in the field of kidney diseases, Chinook aims to deliver transformative treatments to patients while creating value for their stakeholders.
More about Chinook Therapeutics Inc 's Market Share
|
Mirati Therapeutics Inc
Share Performance
+3.77%
This Quarter
|
Mirati Therapeutics Inc
Profile
Mirati Therapeutics Inc is a biotechnology company that focuses on the research, discovery, and development of precision oncology treatments for patients with cancer. Their business model involves leveraging their proprietary drug discovery platform to identify and develop targeted therapies, and collaborating with partners for the commercialization of their products.
More about Mirati Therapeutics Inc 's Market Share
|
Eli Lilly And Company
Share Performance
+0.35%
30 Days
|
Eli Lilly And Company
Profile
Eli Lilly and Company operates as a global pharmaceutical firm that focuses on developing innovative medicines in areas such as diabetes, oncology, and neurodegeneration. Their business model emphasizes research and development, strategic partnerships, and a strong commitment to improving patient outcomes through advanced therapeutics.
More about Eli Lilly And Company's Market Share
|
Merck and Co Inc
Share Performance
-37.71%
One Year
|
Merck and Co Inc
Profile
Merck & Co. Inc. operates primarily as a research-driven pharmaceutical company, focused on the development, manufacturing, and marketing of prescription drugs and vaccines globally. It aims to address unmet medical needs through innovative research, collaborations, and rigorous clinical trials, while promoting patient well-being and contributing to global healthcare with high-quality, affordable medications.
More about Merck and Co Inc 's Market Share
|
Bristol myers Squibb Company
Share Performance
-18.06%
30 Days
|
Bristol myers Squibb Company
Profile
Bristol Myers Squibb Company operates a research and development-driven business model, focusing on the discovery and delivery of innovative medicines for various diseases. It emphasizes collaboration with academic institutions, government entities, and other pharmaceutical firms to enhance its therapeutic portfolio and improve patient outcomes.
More about Bristol myers Squibb Company's Market Share
|
Infinity Pharmaceuticals Inc
Share Performance
-99.34%
One Year
|
Infinity Pharmaceuticals Inc
Profile
Infinity Pharmaceuticals Inc's business model revolves around the discovery, development, and commercialization of innovative therapies for the treatment of challenging diseases, primarily in the field of oncology.
More about Infinity Pharmaceuticals Inc 's Market Share
|
Keros Therapeutics Inc
Share Performance
+25.62%
This Quarter
|
Keros Therapeutics Inc
Profile
Keros Therapeutics Inc's business model is focused on the development of therapeutics to address significant unmet needs in various diseases by targeting specific protein elements within the cell signaling pathways.
More about Keros Therapeutics Inc 's Market Share
|
Sources: Fibrogen Inc and all companies mentioned above in this report
|
